Maximizing Brain Health after Hemorrhagic Stroke: Bugher Foundation Centers of Excellence

Kevin N. Sheth; Christopher D. Anderson; Alessandro Biffi; Nomazulu Dlamini; Guido J. Falcone; Christine K. Fox; Heather J. Fullerton; Steven M. Greenberg; J. Claude Hemphill; Anthony Kim; Helen Kim; Nerissa U. Ko; Jarod L. Roland; Lauren H. Sansing; Susanne J. Van Veluw; Jonathan Rosand

doi:10.1161/STROKEAHA.121.036197

Maximizing Brain Health after Hemorrhagic Stroke: Bugher Foundation Centers of Excellence

Kevin N. Sheth, Christopher D. Anderson, Alessandro Biffi, Nomazulu Dlamini, Guido J. Falcone, Christine K. Fox, Heather J. Fullerton, Steven M. Greenberg, J. Claude Hemphill, Anthony Kim, Helen Kim, Nerissa U. Ko, Jarod L. Roland, Lauren H. Sansing, Susanne J. Van Veluw, Jonathan Rosand

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	1020-1029
Number of pages	10
Journal	Stroke
Volume	29
Issue number	2
DOIs	https://doi.org/10.1161/STROKEAHA.121.036197
State	Published - Mar 1 2022

Keywords

comorbidities
hemorrhagic stroke
intracerebral hemorrhage
morbidity
mortality

Access to Document

10.1161/STROKEAHA.121.036197

Cite this

Sheth, K. N., Anderson, C. D., Biffi, A., Dlamini, N., Falcone, G. J., Fox, C. K., Fullerton, H. J., Greenberg, S. M., Hemphill, J. C., Kim, A., Kim, H., Ko, N. U., Roland, J. L., Sansing, L. H., Van Veluw, S. J., & Rosand, J. (2022). Maximizing Brain Health after Hemorrhagic Stroke: Bugher Foundation Centers of Excellence. Stroke, 29(2), 1020-1029. https://doi.org/10.1161/STROKEAHA.121.036197

@article{77a06f06945c45c8ad16754f315b529b,

title = "Maximizing Brain Health after Hemorrhagic Stroke: Bugher Foundation Centers of Excellence",

keywords = "comorbidities, hemorrhagic stroke, intracerebral hemorrhage, morbidity, mortality",

author = "Sheth, {Kevin N.} and Anderson, {Christopher D.} and Alessandro Biffi and Nomazulu Dlamini and Falcone, {Guido J.} and Fox, {Christine K.} and Fullerton, {Heather J.} and Greenberg, {Steven M.} and Hemphill, {J. Claude} and Anthony Kim and Helen Kim and Ko, {Nerissa U.} and Roland, {Jarod L.} and Sansing, {Lauren H.} and {Van Veluw}, {Susanne J.} and Jonathan Rosand",

note = "Funding Information: Dr Sheth is supported by the National Institutes of Health (NIH; U24NS107136, U24NS107215, R01NR018335, R01NS110721, R03NS112859, U01NS106513, and 1U01NS106513-01A1) and the American Heart Association (17CSA33550004), as well as research grants from Hyperfine Research, Inc, Bard, and Biogen. He also serves as the DSMB chair for a Zoll sponsored stroke study and receives equity from Alva Health and Astrocyte. Dr Anderson is supported by the NIH (R01NS103924 and U01NS069763), the American Heart Association (18SFRN34250007 and 812095), Bayer AG, and Massachusetts General Hospital, and has served as a consultant for ApoPharma and Invitae. Dr Biffi is supported by the NIH (K23NS100816) and the American Heart Association (AHA; 814721). Dr Greenberg is supported by the NIH (R01NS096730 and RO1AG26484) and the American Heart Association (812095). Dr van Veluw is supported by the NIH (R00AG059893, R21AG070363) and the American Heart Association (814728). Dr Rosand supported by the NIH (R01NS036695, R01NS093870, R01NS100178, R01NS103924, R01AG067019, U01NS102289, and UO1NS069763) and the American Heart Association (812095). He serves as a consultant to Takeda. Dr Fullerton is supported by the NIH (R01NS104094 and K12NS098482) and the American Heart Association (813224). Dr Fox is supported by the NIH (R01NS104094) and the American Heart Association (814692). Dr Kim is supported by the NIH (R01NS099268, R01NS112819, R01NS114552, U01 NS104157, U54 NS065705) and the American Heart Association (814693). She serves as a consultant to Recursion Pharmaceuticals. The other authors report no conflicts.",

year = "2022",

month = mar,

day = "1",

doi = "10.1161/STROKEAHA.121.036197",

language = "English",

volume = "29",

pages = "1020--1029",

journal = "Stroke",

issn = "0039-2499",

number = "2",

}

Sheth, KN, Anderson, CD, Biffi, A, Dlamini, N, Falcone, GJ, Fox, CK, Fullerton, HJ, Greenberg, SM, Hemphill, JC, Kim, A, Kim, H, Ko, NU, Roland, JL, Sansing, LH, Van Veluw, SJ & Rosand, J 2022, 'Maximizing Brain Health after Hemorrhagic Stroke: Bugher Foundation Centers of Excellence', Stroke, vol. 29, no. 2, pp. 1020-1029. https://doi.org/10.1161/STROKEAHA.121.036197

TY - JOUR

T1 - Maximizing Brain Health after Hemorrhagic Stroke

T2 - Bugher Foundation Centers of Excellence

AU - Sheth, Kevin N.

AU - Anderson, Christopher D.

AU - Biffi, Alessandro

AU - Dlamini, Nomazulu

AU - Falcone, Guido J.

AU - Fox, Christine K.

AU - Fullerton, Heather J.

AU - Greenberg, Steven M.

AU - Hemphill, J. Claude

AU - Kim, Anthony

AU - Kim, Helen

AU - Ko, Nerissa U.

AU - Roland, Jarod L.

AU - Sansing, Lauren H.

AU - Van Veluw, Susanne J.

AU - Rosand, Jonathan

N1 - Funding Information: Dr Sheth is supported by the National Institutes of Health (NIH; U24NS107136, U24NS107215, R01NR018335, R01NS110721, R03NS112859, U01NS106513, and 1U01NS106513-01A1) and the American Heart Association (17CSA33550004), as well as research grants from Hyperfine Research, Inc, Bard, and Biogen. He also serves as the DSMB chair for a Zoll sponsored stroke study and receives equity from Alva Health and Astrocyte. Dr Anderson is supported by the NIH (R01NS103924 and U01NS069763), the American Heart Association (18SFRN34250007 and 812095), Bayer AG, and Massachusetts General Hospital, and has served as a consultant for ApoPharma and Invitae. Dr Biffi is supported by the NIH (K23NS100816) and the American Heart Association (AHA; 814721). Dr Greenberg is supported by the NIH (R01NS096730 and RO1AG26484) and the American Heart Association (812095). Dr van Veluw is supported by the NIH (R00AG059893, R21AG070363) and the American Heart Association (814728). Dr Rosand supported by the NIH (R01NS036695, R01NS093870, R01NS100178, R01NS103924, R01AG067019, U01NS102289, and UO1NS069763) and the American Heart Association (812095). He serves as a consultant to Takeda. Dr Fullerton is supported by the NIH (R01NS104094 and K12NS098482) and the American Heart Association (813224). Dr Fox is supported by the NIH (R01NS104094) and the American Heart Association (814692). Dr Kim is supported by the NIH (R01NS099268, R01NS112819, R01NS114552, U01 NS104157, U54 NS065705) and the American Heart Association (814693). She serves as a consultant to Recursion Pharmaceuticals. The other authors report no conflicts.

PY - 2022/3/1

Y1 - 2022/3/1

KW - comorbidities

KW - hemorrhagic stroke

KW - intracerebral hemorrhage

KW - morbidity

KW - mortality

UR - http://www.scopus.com/inward/record.url?scp=85125554521&partnerID=8YFLogxK

U2 - 10.1161/STROKEAHA.121.036197

DO - 10.1161/STROKEAHA.121.036197

M3 - Review article

C2 - 35109678

AN - SCOPUS:85125554521

SN - 0039-2499

VL - 29

SP - 1020

EP - 1029

JO - Stroke

JF - Stroke

IS - 2

ER -

Maximizing Brain Health after Hemorrhagic Stroke: Bugher Foundation Centers of Excellence

Keywords

Access to Document

Other files and links

Cite this